# SELUTION4BTK Trial

Study · id `cardio:ct-nct05055297` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05055297](<https://clinicaltrials.gov/study/NCT05055297>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05055297

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 376 participants.

## Technical summary

Registry record NCT05055297. Randomized; single masking; primary purpose treatment. Start 2022-05-19 (actual); primary completion 2027-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 376 participants (planned count; ClinicalTrials.gov record NCT05055297, source copy `cardio:ctgov-nct05055297-2026-04-28`, retrieved 2026-10-31)
- Started: 2022-05-19 (actual) (ClinicalTrials.gov record NCT05055297, source copy `cardio:ctgov-nct05055297-2026-04-28`, retrieved 2026-10-31)
- Primary completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT05055297, source copy `cardio:ctgov-nct05055297-2026-04-28`, retrieved 2026-10-31)
- Completion: 2032-07-30 (anticipated) (ClinicalTrials.gov record NCT05055297, source copy `cardio:ctgov-nct05055297-2026-04-28`, retrieved 2026-10-31)
- Countries: United States; Austria; France; Germany; Hong Kong SAR China; Italy; Netherlands; New Zealand; Singapore; Switzerland (ClinicalTrials.gov record NCT05055297, source copy `cardio:ctgov-nct05055297-2026-04-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05055297-2026-04-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: SELUTION4BTK Trial
- Condition: Peripheral Arterial Disease
- Condition: Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
- Intervention (Device): SELUTION SLR™ DEB 014
- Intervention (Device): Plain (Uncoated) Balloon Angioplasty (PTA)
- Lead sponsor: M.A. Med Alliance S.A.
- Lead sponsor class: INDUSTRY
- Collaborator: NAMSA
- Collaborator class: OTHER
- Collaborator: Cordis US Corp.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: M.A. Med Alliance S.A. (`cardio:org-m-a-med-alliance-s-a`)
- Registry lists this organization as a collaborator: Cordis US Corp. (`cardio:org-cordis-us-corp`)

## Provenance

Content hash: 7635adf70472934fabf8c7f50ee5ce90cc63fd740cee979ef733e41a7a58316d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
